HIV/AIDS remains a major global health problem, despite the progress made in its prevention and treatment. Addressing this problem is not only a matter of more and better drugs, they need to be widely accessible and be affordable to the poor. This book makes, with a much welcomed interdisciplinary approach, an excellent contribution to understanding how the intellectual property regime can influence health policies and the lives of millions of people affected by the disease. The analysis provided by the various authors that contributed to this book will be of relevance not only to those working in the area of HIV/AIDS, but to those more broadly interested in public health governance and the role of intellectual property rights.' - Carlos Correa, University of Buenos Aires, Argentina'This is an important, innovative and, at times, controversial collection. Inter-disciplinary in approach, this collection will have appeal to those concerned with the global injustice in the context of HIV/AIDS. Investigating the legal, political and economic determinants of access to essential medicines, this is thought provoking collection which will resonate with many in both the academic and public policy community.' - Bryan Mercurio, The Chinese University of Hong Kong This important book brings together leading scholars from multiple disciplines, including intellectual property, human rights, public health, and development studies, as well as activists to critically reflect on the global health governance regime. The Global Governance of HIV/AIDS explores the implications of high international intellectual property standards for access to essential medicines in developing countries. With a focus on HIV/AIDS governance, the volume provides a timely analysis of the international legal and political landscape, the relationship between human rights and intellectual property, and emerging issues in global health policy. It concludes with concrete strategies on how to improve access to HIV/AIDS medicines. This interdisciplinary, global, and up-to-date book will strongly appeal to academics in law, international relations, health policy and public policy, as well as students, policymakers and activists. Contributors include: F.M. Abbott, O. Aginam, T. Amin, L. Biron, A. Denburg, G.E. Evans, J. Harrington, J. Harrison, K. Lee, K.C. Shadlen, P.K. Yu

It's been likened to a plague, but AIDS was never just a health crisis. The second of a series on grieving the death of a friend, Grief and AIDS: Thirty Years of Burying Our Friends, revisits a time when people with AIDS were also victims of bigotry and discrimination. In stories about Ryan White, ACT UP, the Names Project, red ribbons and more, you'll learn why friends made all the difference: not just caregiving or memorializing, but changing the way society confronts the medical establishment and government to demand action.

This Training Guide was developed to assist Title I HIV planning councils and Title II care consortia in ensuring that all members have the information and skills for full participation in Ryan White Comprehensive AIDS Resources Emergency (CARE) Act planning and implementation activities, with special emphasis on PLWH members . Successful implementation of the CARE Act depends upon the work of planning bodies in communities throughout the nation, and requires that members be diverse, active, and well informed. PLWH involvement in such planning bodies is both a legislative requirement and a practical necessity . The CARE Act, enacted in 1990 and reauthorized in 1996, requires planning councils and consortia to include members from affected communities, including people living with HIV/AIDS (PLWHs). The Division of HIV Services (DHS), which administers Title I and Title II of the CARE Act, believes that effective programs and services must be developed based on the input and perspectives of those for whom the services are intended. The Training Guide was initiated to address the need for orientation and training for planning body members who were people living with HIV disease . A consultant to DHS developed the initial outline. Subsequently, DHS staff and participants in the third Community Discussion Group meeting in October 1995 reviewed, revised, and expanded it. The resulting content outline became the basis for this guide, prepared by MOSAICA: The Center for Nonprofit Development and Pluralism through an interactive process with the PLWH Response Committee of DHS and with John Snow, Inc., the Ryan White Technical Assistance Contractor. Following review of the draft guide, DHS decided that a Training Guide was needed not just for PLWHs but for all planning body members. The guide therefore provides information that can be used for providing orientation and ongoing training to all planning body members, including people living with HIV disease.

People who inject drugs (PWID) are at higher risk for acquiring HIV infection than the general population in many countries. Injecting drug use is present in 148 countries including a wide array of low and middle income countries where HIV incidence is growing in recent years - even as it declines elsewhere. This study was undertaken as the third of a series of three economic analyses examining the global epidemics of HIV/AIDS in vulnerable populations. Informed by a critical review of epidemiological evidence and the most recent analyses of intervention efficacy, this work modelled the costs and impact of addressing the needs of PWID at scale in various epidemic contexts. These particular research questions were addressed: What are the modelled epidemic impact and costs of implementing a minimum adaptable package of evidence-based and human rights affirming services for prevention, treatment, and care of HIV/AIDS in PWID in globally representative epidemic scenarios? What are the estimated returns on investment and costs of inaction of addressing these epidemics? Taken together, the findings indicate: Service coverage levels for ART and key harm reduction interventions with HIV prevention benefits are generally inadequate. Allocative decisions for HIV/AIDS should better reflect the burden of transmission and disease. HIV transmission dynamics can be significantly reduced by scaling up a package of four key harm reduction interventions specific to PWID: Needle and Syringe Programs, Medically Assisted Therapy and HIV Counseling and Testing, as well as proportionate access in ART scale-up. Evidence-based and effective interventions for PWID should be funded and implemented - in the context of HIV prevention services for the general population, such as condom promotion. Interventions for PWID - particularly in combination with treatment services - are cost effective or highly cost effective investment choices across the breadth of the global epidemic. The study presents compelling evidence for the most cost-effective approaches to minimising the transmission and impacts of HIV in this key population. This evidence may guide both operational design and policy dialogue in World Bank operations.

On February 23, 2009, a consultation meeting was held to examine the use of peers in HIV interdisciplinary care settings. The meeting was convened by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), HIVAIDS Bureau (HAB). Participants included HRSA representatives, Ryan White HIV/AIDS Program grantees, researchers, technical assistance providers, health care professionals, program managers and HIV positive peers. Participants heard about the ways in which peers were being used in the fields of HIV, cancer and diabetes to facilitate access to care, treatment and health-related services. The purpose of the meeting, explained Steven Young, HAB's Director of Training and Technical Assistance, was to gain greater insight into the benefits and challenges of having peers on health care teams, to identify the major components of an ideal peer program, and to make recommendations regarding ways in which peer interventions could be funded and sustained within HIV systems of care. Young explained that in the Ryan White HIV/AIDS Program, peers are HIV positive individuals who share identifying characteristics with individuals or population groups receiving care or services. Peers and clients share similar experiences and challenges related to class, race, age, gender, language, culture and recovery from substance abuse and/or trauma. These common characteristics often provide peers with deep insight into the feelings and behaviors of clients, and help them forge both personal credibility and trusting relationship with clients. In the field, said Young, peers are also called coaches, community health workers and patient navigators, among other titles. HAB's particular interest is in examining the role of peers on interdisciplinary health care teams, whose focus in the Ryan White HIV/AIDS Program is to engage and retain clients in high quality, HIV care. Young emphasized the important role that peers (also called consumers) have played in the Ryan White HIV/AIDS Program since its inception. Peers participate in program planning activities, serve as grant reviewers, participate on program advisory committees and boards, and hold positions as volunteers and staff at local health clinics and community-based organizations (CBOs). They serve as faculty of the AIDS Education and Training Centers program. HAB cooperative agreements and grants have supported leadership development for peers to promote their involvement in HIV/AIDS programs. "On an individual level, we have heard from peers that involvement in our programs helps them feel less isolated and gives them an increased sense of purpose," said Young. He added that peers can help improve HIV health care delivery and assessment of client needs, as well as reduce cultural and linguistic barriers, and stigma. Despite widespread acknowledgement within Ryan White that peers play a beneficial role, their function has not been well documented or codified. As a result, HAB is seeking guidance on: Training and support needs of peers; Ideal roles for peers (i.e., staff, volunteers, etc); Financial support for the peer role (grants, reimbursement, etc.); Identification of reasonable client and organizational outcomes related to the use of peers; and Suggestions on how peers might be integrated into specific, legislatively identified core services, such as medical case management and adherence support.

People with HIV/AIDS can live longer, healthier lives because of advances in treatment of HIV infection. However, longer lives are associated with increased prevalence of 1) adverse effects of HIV infection, 2) adverse effects of the drugs used to treat HIV, and 3) concurrent medical conditions that would occur in the absence of HIV. These long-term complications have put HIV infection in the realm of chronic diseases rather than of infectious diseases, which usually respond to short-term clinical interventions. Effective management of chronic diseases in the primary care setting requires the coordination of interventions that occur at the level of the clinical services, the community supports for those clinical services, and the individual patient. While clinical services begin in the primary care clinic, community supports are needed, and the patient must be engaged to enhance self-management. The coordinated interventions together contribute to the desired clinical outcomes. The Chronic Care Model, which is used in the design and quality improvement activities of clinical services, conceptualizes how these factors impact the clinical outcome of chronic disease management. This book addresses several important aspects of HIV/AIDS care and treatment in a concise, accessible format; it is not meant to be a comprehensive reference book. Recommended references and citations are provided for the reader to be able to access in-depth information on topics that are particularly important and/or controversial. Appropriate use of antiretroviral drugs, treatment of opportunistic infections, symptom management, treatment of concurrent medical conditions, and other specific interventions to treat HIV disease and its complications are addressed. The format of this guide is designed to provide practical information for the common questions that arise in the care of patients with HIV infection. Recognizing the broader array of best practices that contribute to effective clinical outcomes among patients with a complex array of service needs, the authors also address patient evaluation, adherence, mental health, substance abuse, overall clinic management, and other factors that lead to improved patient outcomes according to the Chronic Care Model. Last, because the authors recognize the challenges of maintaining clinical practices in the face of rapidly changing and ever more complex treatment interventions, a chapter on sources for updated and in-depth clinical information is provided. Pediatric HIV/AIDS treatment is not addressed in this book.

"Making a Difference " has been developed to help community members to become involved in local decision making that will determine what HIV services are available in their community. While this Consumer Digest may be helpful to many types of community members, its primary purpose is to support persons living with HIV disease to be effective participants on Ryan White planning bodies. Whether you already are involved in your planning body process or wish to learn more before Making the Commitment to get involved, Making a Difference can help you. The CARE Act (Comprehensive AIDS Resources Emergency) is the Federal law that provides money to cities, States, community-based organizations and other types of organizations to provide HIV services. The CARE Act specifically requires that HIV services planning bodies include persons living with HIV disease. These Title I planning councils and Title II planning bodies and consortia (collectively referred to as Ryan White planning bodies throughout this document) have a big impact on determining the types of HIV services - and which specific programs - are available in a community. In recent years, Congress has appropriated (or designated) funding in the range of $2 billion per year to support HIV health services through the CARE Act. Much of this money is distributed to States and local governments that rely on planning bodies to help them identify who is affected by the HIV epidemic, set priorities for the types of HIV services that are needed, and determine how best to allocate funding among multiple priorities. Persons living with HIV disease (PLWH) are critical to the success of these planning processes because they bring a perspective that is different from other members and know firsthand what services are needed. They also can help make sure that different groups of PLWH are included in the process and that their service needs are not overlooked. The Health Resources and Services Administration's (HRSA) HIV/AIDS Bureau (HAB) is the Federal agency responsible for administering the CARE Act. HAB produced this Consumer Digest with the assistance of PLWH members of planning bodies and PLWH trainers at national HIV/AIDS organizations. This document provides new information regarding the CARE Act Amendments of 2000 related to PLWH involvement, and draws upon other publications and materials useful to PLWH on (or considering serving on) a planning body. This digest is intended to provide you with information and tools to help you Make a Difference by serving your community as an active and informed member of a Ryan White planning body.

The Ryan White HIV/AIDS Program was borne of a movement that began with the onset of the AIDS epidemic in America. First by the tens, then by the hundreds, then by the thousands, brave and commit-ted people from all walks of life made a decision to get involved. Some were public health officials; others were activists. Some were community leaders, and others-at least until that time-were citizens quietly living their lives. In this sixth edition of the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) Progress Report, we celebrate the legacy of those first responders. We also celebrate the incredible journey we have taken since 1990, when the first Ryan White Comprehensive AIDS Resources Emergency (CARE) Act was passed into law. Who could have imagined in those early years that we would one day have treatments powerful enough to forestall the progression of HIV/AIDS? Who could have known that we would touch so many lives? This year alone, through scores of grantees and providers* in cities and towns across America, the Ryan White HIV/ AIDS Program will serve well over half a million people. We continue to face hurdles in our fight against the epidemic, but we have made enormous progress. Highlights from this year include the following: At $2.29 billion, FY 2010 appropriations for the Program were the largest in Program history; Our AIDS Education and Training Centers (AETCs) conducted more than 18,000 trainings; Under the AIDS Drug Assistance Program (ADAP), we distributed medications to more than 175,000 clients; We treated the people most disproportionately affected by HIV: 73 percent of our clients were racial and ethnic minorities, and 88 percent of our clients had no private health insurance; We conducted research on innovative, replicable models of HIV care to reduce health disparities in women of color, improve access to oral health care, establish linkages between jail settings and HIV primary care, and expand health information technology and electronic medical systems; We have been involved in the Healthy People 2010 broad-based national collaborative to meet the Nation's most pressing health needs; We continue to set the standard for HIV/AIDS care using well-respected performance measures. This response to HIV/AIDS constitutes nothing less than a modern public health miracle. . . and within it lie other miracles, too-like that of an HIV-positive person living into old age, or the promising future that unfolds before the eyes of an HIV-positive adolescent. In this publication, you will read about many of the milestones we have encountered in our 20-year journey and the many qualities that make our team successful. We embarked on a quest that many would not. We stepped up to the plate when others stepped away. And today we constitute a powerful and cohesive force seldom seen in combating a single disease. Our rewards lie in victory after victory over isolation and disease and in the improved lives of our clients. It has been an amazing and empowering journey, and it is not over. We are trained. We are committed. We are full of resolve. And we will not stop. In this Progress Report, we remember and we honor the determination of those first responders and of Ryan White himself. It was the determination to go the distance for people living with HIV/AIDS, what-ever it took and whatever the cost. That determination has never been more alive than it is today.

This document is to help the CARE Act1 community conduct needs assessments so that they can better plan on how to use CARE Act resources to fill gaps in care. It describes the process of needs assessment and provides "how-to" information about tasks ranging from developing an epidemiologic profile to estimating the need for services. The Guide provides: Legislative requirements and HIV/AIDS Bureau (HAB) expectations for each CARE Act title; Types of needs assessment information; Steps in conducting a comprehensive needs assessment; Practical guidance on how to: Prepare an epidemiologic profile; Collect and use surrogate markers for HIV/AIDS, such as co-morbidity data; Collect information from people living with HIV disease (PLWH) and other community representatives through focus groups, surveys, interviews, and community forums; Prepare a resource inventory; Conduct an assessment of provider capacity/capability, and Assess service needs. Ways to use needs assessment results in decision making; The experiences of CARE Act Titles I, II, III, and IV grantees nationwide, and; Information on special HAB needs assessment initiatives (i.e., preparing a joint epidemiologic profile with an HIV prevention community planning body, developing a framework for estimating unmet need). The Needs Assessment Guide was designed for use by all CARE Act titles and can provide a common approach to needs assessment that facilitates cross-title collaboration. Input on its content was provided by HAB staff and a Field Review Group. Title I and Title II needs assessments typically involve planning bodies-Title I HIV services planning councils and Title II regional consortia or Statewide planning entities. Therefore, the roles of planning bodies are described throughout. For Title III or Title IV, the planning body may be an agency's planning committee or executive committee. Many programs also establish advisory bodies that include community and PLWH participation-or there may be no planning body involvement.

This document is provided as an information resource for physicians and other health care professionals to guide them in the appropriate treatment of patients with HIV/AIDS. Recommendations for care and treatment change rapidly, and opinions can be controversial; therefore, physicians and other health care professionals are encouraged to consult other sources, especially manufacturers' package inserts, and confirm the information contained in these tables. The individual physician or other health care professional should use his/her best medical judgment in determining appropriate patient care or treatment because no single reference or service can take the place of medical training, education, and experience. Determination of appropriate treatment is the responsibility of the treating physician

Why is there so little HIV education at present directed towards bisexual men and women? This book offers a critical analysis of the issues in public health research and education that prevent adequate attention from being paid to bisexual realities. Addressing the implications of such limited knowledge, the authors raise important questions about the weaknesses of our current response to the HIV/AIDS pandemic. Through interviews with a variety of bisexual men and women, HIV Prevention and Bisexual Realities uncovers innovative, important directions to consider for more effective HIV prevention strategies. The authors' epistemological and methodological assessments of the current state of HIV/AIDS education will be indispensable for community health educators, policy makers, and those who study or work in public health.

There are various reasons for taking an interest in the treatment for HIV/AIDS. Unfortunately, AIDS has no cure at the moment. But in the absence of a cure, medical science resorts to available treatment options. In seven chapters, this handy book has been designed to help people seek information about treatment strategies for HIV/AIDS. These include: a general introduction to HIV/AIDS antiretroviral therapy (ART) dynamics of ARV drugs merits and demerits of ARV drugs revival of immune systems in HIV infection foundations of immunosuppression hints for the HIV-positive. The book also includes details of websites for further research, review questions for those preparing for coursework or examinations, a glossary of terms and an index. By explaining a complex disease as one that can be understood and managed, HIV/AIDS Treatment Strategies provides clear and useful information about this important subject area. S D Browne-Umar was born on 16 July 1947 in Axim, Ghana. He worked in Ghana and Nigeria as a science educationist prior to being engaged by UNICEF in north-west Nigeria. He was a consultant field investigator for the Ghana AIDS Commission. Currently, Browne-Umar consults on global HIV education and vaccinology.

Journeys Through Darkness is a biography which tells the story of AIDS and related blindness through AIDS warrior and long-term survivor, award-winning legally blind photographer Kurt Weston. The book includes several of his photographs that match the powerful prose of Alina Oswald.

Journeys Through Darkness is a biography which tells the story of AIDS and related blindness through AIDS warrior and long-term survivor, award-winning legally blind photographer Kurt Weston. The book includes several of his photographs that match the powerful prose of Alina Oswald.

Few people realize that the familiar HIV/AIDS global statistics are actually estimates. For example, UNAIDS estimated that the Republic of South Africa (RSA) had 140,000 HIV/AIDS deaths in 1997. However, after tabulating all deaths for 1997, the Republic of South Africa attributed only 6,635 deaths to HIV/AIDS. Such discrepancies are rarely noted. The Republic of South Africa (RSA) stands as the exemplar of these discrepancies. It is reputed to have the world's largest AIDS epidemic with an estimated 5.6 million people living with HIV/AIDS (PLWH) in 2008. Such PLWH estimates, as with the estimates of HIV/AIDS deaths, are highly questionable. HIV/AIDS in South Africa: The Facts and the Fiction clarifies the reasons behind these discrepancies by describing two common misunderstandings of HIV infection that contribute to poor mathematical modeling outcomes. Fully referenced, HIV/AIDS in South Africa: The Facts and the Fiction presents and compares raw numerical data on: ? the tabulated number of HIV/AIDS deaths in the RSA; ? the number of AIDS cases detected by RSA disease surveillance systems; ? UNAIDS/WHO estimates for AIDS deaths in the RSA; and ? UNAIDS/WHO estimates for the number of people living with HIV/AIDS in the RSA. The total cumulative numbers of HIV/AIDS cases in the United States and the cumulative totals for the continent of Africa are also presented for purposes of comparison, and to place the African and RSA data within appropriate epidemiological context. Overall, these data span from 1981 to 2009. Altogether, these data, plus additional information detailing the nature of HIV infection and heterosexual HIV transmission rates, explain why the hyperbolic mathematical estimates and HIV antibody test surveys the primary sources of HIV/AIDS data in Africa are simply implausible. Contents: 118 pages, 20 tables, several side boxes, and 240 references.

"The theory that AIDS originated in African monkeys arose from an incident of laboratory contamination." ? The scientific literature is clear: (1) New York City is the epicenter of the AIDS epidemic; (2) the theory that HIV came from monkeys is a fallacy; the theory that AIDS originated in African monkeys arose from an incident of laboratory contamination; and (3) the African AIDS epidemic-as-holocaust never manifested. "The first Africans diagnosed with AIDS were residents of Belgium." ? Fully referenced, based on a forensic review of over 3000 scientific and medical journal articles, this book redefines global concepts for the prevalence and distribution of HIV infection. For many readers, each page contains a revelation as the Author not only deconstructs many myths and misconceptions, but also describes how the current misconceptions arose. "The first documented case of international HIV transmission occurred between New York City and Copenhagen." ? This book redefines global concepts for the prevalence and distribution of HIV infection, and has powerful implications for HIV/AIDS funding, research prerogatives, and global health care interventions. Chris Jennings (Harvard, B.A., Biology 1976/77) excels at writing scientific books that fulfill the needs of professionals while rendering the science accessible to the average reader. His prior book, Understanding and Preventing AIDS: A Book for Everyone, was favorably reviewed by the New England Journal of Medicine ? adopted for staff education by Massachusetts General Hospital, the hospital affiliated with Harvard Medical School; the U.S. Department of Health and Human Services (HHS); the National Institutes of Allergy and Infectious Diseases (NIAID); and Walter Reed Army Medical Institute ? sold in medical bookstores ? purchased by innumerable city and state health agencies ? and utilized as a textbook at colleges, nursing schools, and public health schools. Contents: 218 pages, 20 tables, innumerable side boxes, and 500 references.

Compelled by his own 2005 HIV diagnosis, journalist John-Manuel Andriote revisits his acclaimed chronicle of the AIDS epidemic in this updated and expanded edition of the University of Chicago Press 1999 hardcover original. Andriote examines the impact of AIDS on individuals and on the gay civil rights movement, from the coming-out revelry of the 1970s to the post-AIDS gay community of the twenty-first century's first decade. Victory Deferred looks at how AIDS has changed both individual lives and national organizations. It tells the story of how a health crisis pushed a disjointed jumble of local activists to become a national visible and politically powerful civil rights movement, a full-fledged minority group challenging the authority of some of the nation's most powerful institutions. Based on hundreds of interviews with those at the forefront of the medical, political, cultural, civic, and national responses to the epidemic, Victory Deferred artfully blends personal narratives with institutional histories and organizational politics to show how AIDS forced gay men from their closets and ghettos into the hallways of power to lobby and into the streets to protest.

Although overall HIV prevalence in South Asia is low, the widespread stigma attached to HIV and AIDS impedes efforts to reach people most in need of prevention, care, and treatment services. To address this challenge, the 2008 South Asia Region Development Marketplace partnership, led by the World Bank, launched a competitive grants program to support innovative community approaches. 'Tackling HIV-Related Stigma and Discrimination in South Asia' summarizes the monitoring, evaluation, and case study data and documents successful community innovations. Twenty-six community groups in Afghanistan, Bangladesh, India, Nepal, Pakistan, and Sri Lanka received funds. The initiatives involved a broad spectrum, including vulnerable groups as well as people living with HIV, the media, local government authorities, health workers, and religious leaders. The interventions used traditional cultural and media approaches to discuss taboo subjects. The reach of the initiatives was amplifi ed by involving opinion leaders. The strategies engaged marginalized groups to design and lead the interventions and to facilitate contact between groups experiencing stigma and the general public to reduce fears and misconceptions about transmission. Projects that combined economic and stigma reduction interventions helped the marginalized populations to overcome the internalized stigma and become empowered to advocate for their rights. 'Tackling HIV-Related Stigma and Discrimination in South Asia' identifies effective strategies to raise awareness and reports on shifts--albeit slow--of attitudes, norms, and behaviors. Through its recommendations for successful interventions to reduce barriers to effective HIV prevention, care, and treatment programs, the book provides a strong foundation on which to build stigma reduction efforts in the region and world.

HIV/AIDS reverses life expectancy gains, erodes productivity, consumes savings and dilutes growth efforts, threatening the realization of the Millennium Development Goals (MDGs) in Africa.The report is the result of an extensive analytical and consultative process begun in 2006, that engaged more than 1,000 people from over 30 countries and many institutions mostly in Africa, as well as UN agencies, multilateral and bilateral donors, and foundations. The report reaffirms the Bank's commitment to combating HIV/AIDS in Africa, moving from its initial emergency response to the next phase, including the goal to provide at least US $250 million annually and to create an Africa HIV/AIDS Incentive Fund to enhance the evidence base, promote the multisectoral response and provide technical support, analysis and policy advice to countries.

Today over 40 million adults and children worldwide are infected with HIV, however knowledge of the disease has increased greatly and the prognosis is now good for those with access to anti-retroviral treatment. For many, HIV is now a long-term chronic condition and with decreased mortality, patient requirements and disease patterns have changed, making it increasingly apparent to health care professionals that the treatment of HIV should include optimum nutrition and healthy lifestyle interventions to help sufferers lead long and healthy lives. In this essential new book an international team of authors under the editorship of Specialist HIV Dietitian Vivian Pribram bring together the latest research to provide the practicing dietitian and nutritionist with a practical guide to the nutritional care of the HIV and AIDS patient. Students and other health care professionals working and studying this area will also find Nutrition and HIV an important and valuable resource.

With improvements in the treatment of HIV disease, gay men in great numbers are surviving--and thriving--into middle and older age. While increased longevity brings new hope, it also raises unanticipated challenges, particularly for gay men who never thought they would live this long: How do I deal with all the physical changes? Who can I rely on as I get older? Is a relationship still in the cards for me? What about sex? How should I prepare for old age?
A one-of-a-kind guide for gay men aging with HIV, Aging with HIV offers an upbeat, down-to-earth approach for adapting to change, whether driven by age, AIDS, or both. Psychotherapist James Masten and physician James Schmidtberger shed light on the many common assumptions and fears of aging with HIV. Aging with HIV provides concrete solutions for facing midlife with a positive outlook, offering a wealth of advice for breaking unhealthy habits and coping mechanisms. The book describes the nine changes common to gay men as they age with HIV, discusses the four challenges of aging, and offers a unique ten-step path to optimal aging with HIV, helping the reader to tailor the book's suggestions to the realities of their lives. Woven throughout the book are first-person narratives from men who recount what worked--and did not work--for them. In addition, Rapid Research, Fast Fact, and Self-Reflection boxes highlight the latest research and challenge readers to take stock of the present--and plan for the future.
An invaluable tool to keep handy and to refer to often, Aging with HIV is an inviting, confident companion to navigating midlife and beyond with HIV.

I Am This One Walking Beside Me is a moving collection of prayers written by Daniel Gebhardt, who has been living with HIV/AIDS for the past 20 years. What makes this book unique is that Gebhardt writes from both a Christian and a gay perspective, providing readers with insight into such topics as everyday living, medical issues, relationships, self-exploration, and death.Each topic contains several meditations, and each individual meditation is followed by a personal prayer. Gebhardt also includes prayers that relate to compassion and a global understanding of the disease that continues to spread, 20+ years after it was first identified.

The new edition of this successful handbook provides a balance of evidence-based information on Genitourinary Medicine (GUM), including HIV/AIDS. It provides high quality, digestible clinical detail and also practical information on the ever-increasing medico-legal, ethical, and procedural issues of growing importance when dealing with these complex topics. Designed primarily for the trainee in GUM, it is also a valuable reference and resource for the specialist physician, nurse, and other professionals working in the field of sexual health. The new edition remains relevant to those working in this field and features practical enhanced sections on contraception and genital dermatology written by specialist contributors, and information for general practitioners in order to provide services for STIs. The book consists of three easy-to-follow sections. The first section deals with routine management within GUM; medico-legal and ethical issues, the standard patient, special situations, and routine clinical and laboratory processes that include simple flow chart guidance on common clinical presentations. The second section details GUM conditions in a disease-orientated style, including STIs and also other genitourinary problems that may present. The third section on HIV provides a contemporary epidemiological overview of this infection, basic viral biology and pathogenesis, a disease-orientated description of conditions both directly related and opportunistic, and their management and data on special situations such as pregnancy. Finally guidance on commonly used abbreviations is shown together with a useful resource directory for staff. In essence this handbook provides a wealth of simple and easy to follow information on STIs and the principles of providing a service including administrative and medico-legal issues that are sometimes difficult to locate. This book will be of global use to all those with an interest in sexual health whatever their level of expertise and wherever they may practice.